GLP-1 Medications: What You Need to Know About Modern Weight Loss Injections

crop nurse with syringe on beige background

GLP-1 Medications: What You Need to Know About Modern Weight Loss Injections

Medications like Ozempic®, Wegovy®, and Mounjaro® have dominated headlines in recent years, hailed as game-changers in the treatment of obesity. As interest grows, so do questions — how do they work? Who are they for? And are they a “magic bullet” for weight loss?

At Zenvité, we take a balanced, evidence-based approach to weight management, including the use of GLP-1 medications where appropriate. Here’s what you need to know about these modern weight loss injections.

What Are GLP-1 Medications?

GLP-1 medications are a class of drugs that mimic the hormone glucagon-like peptide-1 (GLP-1), which helps regulate appetite and blood sugar.

They were originally developed for type 2 diabetes but have since been approved for weight management in people with obesity or overweight and certain health risks.

Common examples include:
🌱 Semaglutide (Ozempic® and Wegovy®)
🌱 Tirzepatide (Mounjaro® – which also targets a second hormone, GIP)

How Do They Work?

GLP-1 receptor agonists act on multiple systems to support weight loss:

Reduce Appetite – they slow gastric emptying and act on brain centres to increase feelings of fullness and reduce cravings.

Improve Blood Sugar Control – by stimulating insulin release and reducing glucagon secretion, they help stabilise glucose levels.

Potential Cardiovascular Benefits – some studies suggest a reduction in cardiovascular events in high-risk patients.

Who Might Benefit From GLP-1 Medications?

GLP-1 medications may be considered if you:
🌱 Have a BMI ≥30 (obesity)
🌱 Have a BMI ≥27 (overweight) plus weight-related health issues such as type 2 diabetes, high blood pressure, or sleep apnoea
🌱 Have tried lifestyle interventions without sufficient success

They are not intended as a first-line treatment but as part of a broader weight management plan.

What to Expect With GLP-1 Treatment

Dosage and Administration

  • Administered as a once-weekly injection (self-administered with a pre-filled pen)

  • Dose typically titrated up gradually to minimise side effects

Weight Loss Outcomes

Clinical trials show average weight reductions of:
✔ 10–15% of body weight with semaglutide (Wegovy®)
✔ Up to 20% with tirzepatide (Mounjaro®)

Results vary and are most sustainable when combined with lifestyle changes.

Common Side Effects

Most are gastrointestinal and often improve over time:
🌱 Nausea
🌱 Diarrhoea or constipation
🌱 Heartburn
🌱 Rarely, more serious risks like pancreatitis or gallbladder issues

Addressing the Myths

“Is It a Quick Fix?”

No. While effective, these medications require ongoing use to maintain benefits. Stopping treatment often leads to weight regain if lifestyle habits haven’t changed.

“Does It Replace Diet and Exercise?”

No. GLP-1 medications work best as part of a comprehensive plan that includes nutrition, movement, sleep, and stress support.

How Zenvité Supports Patients Considering GLP-1s

At Zenvité, we offer:
🌱 Comprehensive health assessments to determine if GLP-1 therapy is appropriate
🌱 Regular monitoring for effectiveness and side effects
🌱 Lifestyle medicine support to build sustainable habits alongside medication
🌱 Tailored weight management plans for long-term success, not short-term fixes

We believe medication can be a powerful tool, but it’s only one part of the picture.

Modern Tools, Holistic Care

GLP-1 medications represent a breakthrough in weight management, but true success comes from integrating them into a whole-person approach.

Book a consultation with Zenvité today to explore whether GLP-1 therapy is right for you — and to build a sustainable plan for your health.

More Posts

Discover more from zenvité

Subscribe now to keep reading and get access to the full archive.

Continue reading